Bio-Techne

Merck Acquires Life Sciences Company Bio-Techne

Merck has agreed to acquire Bio-Techne in an all-cash deal valuing the company at approximately $11.3 billion.

Advancements in Biomanufacturing: The Impact of Analytical Methods

This article collection hopes to provide scientists with more information on biopharmaceutical analytics allowing you to further your research in biomanufacturing.

News

Bio-Techne to buy Exosome Diagnostics

Top-Feature

INOSIM GmbH

Predictive Simulation in Pharma Production

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

From Catalogue to Collaboration

Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Bio-Techne Corporation

Merck KGaA